Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 5929-5935

  Wu, Yu Ling ^a   Jiang, Xu Rong ^a   Newland, Adrian C ^a   Kelsey, Stephen M ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETOPHENONES; ANTIGENS, CD; APOPTOSIS; ARACHIDONIC ACID; CALCIMYCIN; CYTOSOL; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA; MELITTEN; PHOSPHOLIPASES A; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032526890     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93.
2. Kim, M. Y., C. Linardic, L. Obeid, and Y. A. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor and γ-interferon. J. Biol. Chem. 266:484.
3. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. A. Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769.
4. 2 by tumor necrosis factor α. Cancer Res. 52:866.
5. Higuchi, M., and B. B. Aggarwal. 1994. Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol. 152:4017.
6. Vandenabeele, P., W. Declercp, B. Vanhaesebroeck, J. Grooten, and W. Fiers. 1995. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154:2904.
7. Tartaglia, L. A., M. Rothe, Y. F. Hu, and D. V. Goeddel. 1993. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213.
8. Thoma, B., M. Grell, K. Pfizenmaier, and P. Scheurich. 1990. Identification of a 60-kDa tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172:1019.
9. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:3095.
10. 2-released fatty acids is an early event in tumor necrosis factor alpha-treated WEHI-164 cells. Biochem. Biophys. Res. Commun. 221:531.
11. 2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol. Chem. 268:11290.
12. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and inlerleukin-1 signaling. Cell 77:325.
13. Miura, M., R. M. Friedlander, and J. Yuan. 1995. Tumor necrosis factor-induced apoptosis is mediated by CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA 92:8318.
14. 2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272:17196.
15. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
16. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potential ion by inhibition of NF-κB. Science 274:784.
17. Wong, G. H., J. H. Elwell, L. W. Oberley, and D. V. Goeddel. 1989. Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923.
18. Jaattela, M., O. Wissing, P. A. Bauer, and G. C. Li. 1992. Major heat shock protein hsp 70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J. 11:3507.
19. Jaattela, M., H. Mouritzen, F. Elling, and L. Bastholm. 1996. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156:1166.
20. Kobayashi, D., N. Watanabe, N. Yamauchi, N. Tsuji, T. Sato, and Y. Niitsu. 1997. Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood 89:2472.
21. 2. J. Biol. Chem. 267:39.
22. 2 in human melanoma tumor cells. J. Immunol. 156:201.
23. Wu, Y. L., X. R. Jiang, P. D. Allen, L. Jia, D. M. Dronfield, A. C. Newland, and S. M. Kelsey. 1996. Modulation of surface TNF expression by human leukemic cells alters their sensitivity to exogenous TNF. Lenk. Res. 20:47.
24. 2. Cancer Res. 58:633.
25. 2 from human monocytic leukemic U937 cells: calcium-dependent activation and membrane association. J. Biol. Chem. 265:14654.
26. 2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265:5409.
27. Reid, T. R., C. S. Ramesha, and G. M. Ringold. 1991. Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J. Biol. Chem. 266:16580.
28. 2+/calmodulin and protein kinase C regulation of serotonin transport in human K562 lymphocytes. Cell. Immunol. 172:269.
29. 2 in tumor necrosis factor-induced apoptosis. Proc. Natl Acad. Sci. USA 94:5073.